BBIO Buybacks
9 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–9; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| BridgeBio Pharma, Inc. | 2026-03-31 | Reported repurchase cash | $82.5M |
| BridgeBio Pharma, Inc. | 2025-12-31 | Reported repurchase cash | $0.00 |
| BridgeBio Pharma, Inc. | 2025-03-31 | Reported repurchase cash | $48.28M |
| BridgeBio Pharma, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| BridgeBio Pharma, Inc. | 2024-03-31 | Reported repurchase cash | $0.00 |
| BridgeBio Pharma, Inc. | 2021-12-31 | Reported repurchase cash | $1.54M |
| BridgeBio Pharma, Inc. | 2021-03-31 | Reported repurchase cash | $50M |
| BridgeBio Pharma, Inc. | 2020-12-31 | Reported repurchase cash | $0.00 |
| BridgeBio Pharma, Inc. | 2020-03-31 | Reported repurchase cash | $75M |